Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant - Barkan, A L; Burman, P; Clemmons, D R; Drake, W M; Gagel, R F; Harris, P E; Trainer, P J; van der Lely, A J; Vance, M L (J Clin Endocrinol Metab, 2005)